Showing results (1071-1080 of 11,547) with videos related to

Sort By:
Pageof 1,155
British Journal of Clinical Pharmacology|June 1, 1992
The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjectsR Pöyhiä, T Seppälä, K T Olkkola, et al.
British Journal of Clinical Pharmacology|June 1, 1992
The pharmacokinetics of mecillinam and pivmecillinam in pregnant and non-pregnant womenA Heikkilä, K Pyykkö, R Erkkola, et al.
British Journal of Clinical Pharmacology|June 1, 1992
The influence of particle size on the bioavailability of inhaled temazepamJ P Fee, P S Collier, A P Launchbury, et al.
British Journal of Clinical Pharmacology|September 1, 1992
N-demethylation of ethylmorphine in pregnant and non-pregnant women and in men: an evaluation of the effects of sex steroidsE Gerdin, A Rane
British Journal of Clinical Pharmacology|September 1, 1992
Ipratropium bromide delivered orally by metered dose inhaler does not decrease salivary flow in normal subjectsV E Thomas, F O'Connell, A J Harrison, et al.
British Journal of Clinical Pharmacology|December 4, 2003
The effects of KT3-671, a new angiotensin II (AT 1) receptor blocker in mild to moderate hypertensionD Patterson, J Webster, G McInnes, et al.
British Journal of Clinical Pharmacology|December 4, 2003
Steady-state pharmacokinetics and pharmacodynamics of cysteamine bitartrate in paediatric nephropathic cystinosis patientsEric B Belldina, Mei Y Huang, Jerry A Schneider, et al.
British Journal of Clinical Pharmacology|December 4, 2003
Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in humanN Cazali, A Tran, J M Treluyer, et al.
British Journal of Clinical Pharmacology|December 4, 2003
An in vitro interethnic comparison of monoamine oxidase activities between Japanese and Caucasian livers using rizatriptan, a serotonin receptor 1B/1D agonist, as a model drugT Iwasa, H Sano, A Sugiura, et al.
British Journal of Clinical Pharmacology|November 18, 2003
Population pharmacokinetic modelling of darifenacin and its hydroxylated metabolite using pooled data, incorporating saturable first-pass metabolism, CYP2D6 genotype and formulation-dependent bioavailabilityThomas Kerbusch, Ulrika Wählby, Peter A Milligan, et al.
Pageof 1,155